Phone: (402) 280-5009
Address: Division of Surgical Oncology, Suite 3700 601 North 30th Street Omaha, Nebraska 68131

Get Help Contacting This Doctor

Dr. Loggie is currently holds several distinguished titles and positions, including: Professor of Surgery at Creighton University School of Medicine in Omaha, Nebraska, as well as acting as the school’s director for their Cancer Biology Program. He is also chief of the Division of Surgical Oncology for Creighton University’s Cancer Center. Dr. Loggie is a Diplomat of the American Board of Surgery since 1990 and Endowed Bonnstetter Chair. Dr. Loggie has various areas of special interest and expertise, namely:

Peritoneal carcinomatosis and malignant ascites
Peritoneal mesothelioma
Abdominopelvic and retroperitoneal sarcomas
Pseudomyxoma peritonei
Cutaneous malignant melanoma
Sphincter preserving treatment for rectal tumors
Management of complex primary or recurrent solid tumors
Education and Training

Dr. Loggie’s undergraduate work was completed at Loyola College in Montreal, Canada in 1974, after which he earned his medical degree in 1979 from McGill University, also located in Montreal. Following his education, Dr. Loggie participated in an internship at the Department of Surgery, Montreal General Hospital and completed his residency in surgery in 1986 at the same location.

He achieved further education and training during his residency in surgery, concurrently completing graduate studies at the McGill University in the Department of Experimental Surgery. Dr. Loggie conducted his clinical and research fellowship in Surgical Oncology at the Division of Surgical Oncology, at the University of Illinois, in Chicago. He received his certificate of training in Surgical Oncology from the University of Illinois School Of Medicine.

Research and Publications

A selection of Dr. Loggie’s publications and abstracts, specifically those dealing with mesothelioma are listed below:

Loggie BW, Fleming RA, McQuellon RP, et al. Prospective trial for the treatment of malignant peritoneal mesothelioma. Am Surg 2001;67:999-1003.
Loggie BW. Malignant peritoneal mesothelioma. Current Treatment Options in Oncology 2001:2:395-9.
Loggie BW, Perini M, Fleming RA, et al. Treatment and prevention of malignant ascites associated with disseminated intraperitoneal malignancies by aggressive combined-modality therapy. Am Surg 1997;63:137-43
He has also received grants in the following areas of study and research:

1995-1998 Surgically Directed Hyperthermic Chemotherapy. NIH Grant #1 RO1 CA67809-01 Principal Investigator.
2002-2003 Cancer Biology. State of Nebraska-LB692
2002-2004 Relationship Between Transcriptional Modulator (E6-AP), Tumor Suppressor (P53) and Mucin Expression in Breast and Colon Cancer. State of Nebraska-LB595


Mesothelioma Symptoms was founded by a team of advocates to educate people about this aggressive form of cancer. Mesothelioma affects thousands of people each year. We help give hope to those impacted by mesothelioma.

Get Immediate Help

Call Today. Patient Advocates Are Standing By to Help You.

Being diagnosed with mesothelioma is a very stressful time. Our patient advocates have over 20 years of successfully guiding mesothelioma patients to access treatment and pursue compensation. Let us help you too.

  • Locate top mesothelioma doctors
  • File your mesothelioma claim
  • Access the latest clinical trials

Our patient advocates are ready to help. Call today at (888) 360-2406.

Connect With a Patient Advocate Now